Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Published:2003-02 Issue:4 Volume:88 Page:491-495
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Lorusso V,Crucitta E,Silvestris N,Catino A,Caporusso L,Mazzei A,Guida M,Latorre A,Sambiasi D,D'Amico C,Schittulli F,Calabrese P,De Lena M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600780.pdf

Reference33 articles.

1. Bennett JM, Muss HB, Doroshow JH, Wolff S, Krementz ET, Cartwrigth K, Dukart G, Reisman A, Schoch I (1988) A randomised multicenter trial comparing mitoxantrone, cyclophosphamide and fluorouracil with doxorubicin, cyclophosphamide and fluorouracil in the therapy of metastatic breast cancer. J Clin Oncol 6: 1611–1620

2. Black RJ, Bray F, Ferlay J, Parkin DM (1997) Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33: 1075–1107

3. Blackstein M, Vogel CL, Ambinder R, Cowan J, Pearce P, Iglesias J (1997) Phase II study of gemcitabine in patients with metastatic breast cancer. The European Cancer Conference, Hamburg, 14–18 September. Eur J Cancer 33 (Suppl 8): S149 (Abstract 664)

4. Brufman G, Haim N, Ben-Baruch N, Sulkes A (1993) Second-line chemotherapy with mitoxantrone as a single agent in metastatic breast cancer. J Chemother 5: 43–46

5. Carmichael J, Possinger K, Phillip P, Beykirch M, Kerr H, Walling J, Harris AL (1995) Advanced breast cancer: a phase II trial with gemcitabine. J Clin Oncol 13: 2731–2736

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review;Journal of Oncology Pharmacy Practice;2021-02-04

2. In silico drug repositioning based on drug-miRNA associations;Briefings in Bioinformatics;2019-02-11

3. Synthesis of 2-Substituted Benzothiazole Derivatives and Their In Vitro Anticancer Effects and Antioxidant Activities Against Pancreatic Cancer Cells;Anticancer Research;2017-10-23

4. A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium;British Journal of Cancer;2015-11-10

5. Gemcitabine-induced cardiomyopathy: a case report and review of the literature;Journal of Medical Case Reports;2014-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3